Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01675427 · ClinicalTrials.gov registry record · Phase 4

A Study on the Correlation Between Interleukin 28B Genotypes With Clinical and Demographic Characteristics in Treatment-Naïve and Treatment-Experienced Patients With Chronic Hepatitis C

A Phase 4 study of Hepatitis C, Chronic, sponsored by Hoffmann-La Roche.

Completed
Registry status
Phase 4
Development phase
4,766
Enrollment target
20
Study locations

NCT01675427 is a Phase 4 study of Hepatitis C, Chronic that has completed, run by Hoffmann-La Roche. The registered enrollment target is 4,766 participants, above the 193-participant average among 26 other Hepatitis C, Chronic trials with a reported enrollment target (2369% higher). The trial reports 20 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01675427, a Phase 4 study of Hepatitis C, Chronic, has completed, sponsored by Hoffmann-La Roche.

COMPLETED
Registry status
Phase 4
Development phase
4,766 participants
Enrollment target
20
Study locations

Study Summary

This multicenter study will evaluate the correlation of interleukin 28B (IL28B) genotypes with disease characteristics and demographics in treatment-naïve and treatment-experienced chronic hepatitis C patients, including patients with HIV co-infection. There will be a single study visit for testing.

Conditions Studied

Hepatitis C, Chronic

Interventions

  • OTHER Interleukin 28B testing

Study Locations (20)

Other

  • - Buenos Aires
  • - Mar del Plata
  • - Antwerp
  • - Bruges
  • - Brussels
  • - Brussels
  • - Brussels
  • - Brussels
  • - Brussels
  • - Brussels
  • - Edegem
  • - Genk
  • - Ghent
  • - Hasselt
  • - Heusy
  • - Kortrijk
  • - Leuven
  • - Liège
  • - Ostend

Virginia

  • - Alexandria

Trial Details

FieldValue
Enrollment Target 4,766 participants
Start Date 2011-08
Est. Completion 2013-10
Phase Phase 4

Sponsor

Hoffmann-La Roche

909 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01675427

The ClinicalTrials.gov registry entry for NCT01675427 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 4,766 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 193-participant average among 26 other Hepatitis C, Chronic trials with a reported enrollment target (2369% higher). The listed sponsor is Hoffmann-La Roche, which has 909 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Hepatitis C, Chronic appearing as the primary indexed condition, and to 1 intervention - of which Interleukin 28B testing is the first listed.

NCT01675427 reports 20 study locations spanning 2 distinct geographic areas - top geographies include Other, Virginia.

Frequently Asked Questions

What is clinical trial NCT01675427 about?

NCT01675427 is a clinical study titled "A Study on the Correlation Between Interleukin 28B Genotypes With Clinical and Demographic Characteristics in Treatment-Naïve and Treatment-Experienced Patients With Chronic Hepatitis C". This multicenter study will evaluate the correlation of interleukin 28B (IL28B) genotypes with disease characteristics and demographics in treatment-naïve and treatment-experienced chronic hepatitis C patients, including patients with HIV co-infection. There will be a single study visit for testing.

What is the current status of trial NCT01675427?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 4,766 participants. The study started on 2011-08. Estimated completion is 2013-10.

What conditions does trial NCT01675427 study?

This clinical trial studies the following conditions: Hepatitis C, Chronic.

What interventions are being tested in trial NCT01675427?

The interventions under investigation include: Interleukin 28B testing (OTHER).

Who is sponsoring clinical trial NCT01675427?

This trial is sponsored by Hoffmann-La Roche, which has 909 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01675427 being conducted?

This trial has 20 study locations across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Hepatitis C, Chronic

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Hepatitis C, Chronic

All registered trials for this condition

Virginia

All trials with a study site in Virginia

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.